Total Payments
$18,017
2024 Payments
$3,483
Companies
72
Transactions
981
Medicare Patients
2,106
Medicare Billing
$306,962
Payment Breakdown by Category
Food & Beverage$17,985 (99.8%)
Education$31.58 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,985 | 979 | 99.8% |
| Education | $31.58 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,070 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,639 | 115 | $0 (2024) |
| ABBVIE INC. | $1,263 | 116 | $0 (2024) |
| Amgen Inc. | $1,006 | 34 | $0 (2023) |
| EMD Serono, Inc. | $996.72 | 53 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $893.22 | 48 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $707.88 | 15 | $0 (2021) |
| Lilly USA, LLC | $670.40 | 43 | $0 (2024) |
| PFIZER INC. | $654.90 | 53 | $0 (2024) |
| SK Life Science, Inc. | $570.17 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,483 | 173 | UCB, Inc. ($397.54) |
| 2023 | $2,462 | 172 | PFIZER INC. ($400.73) |
| 2022 | $3,263 | 192 | Biohaven Pharmaceutical Holding Company Ltd. ($534.00) |
| 2021 | $2,959 | 130 | Biohaven Pharmaceuticals, Inc. ($532.00) |
| 2020 | $1,905 | 91 | UCB, Inc. ($262.84) |
| 2019 | $1,224 | 84 | UCB, Inc. ($243.47) |
| 2018 | $1,721 | 80 | Amgen Inc. ($530.06) |
| 2017 | $999.72 | 59 | Avanir Pharmaceuticals, Inc. ($293.88) |
All Payment Transactions
981 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neurology | ||||||
| 11/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Pain Management | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $126.65 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: EPILEPSY | ||||||
| 11/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: PAIN | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Neurology | ||||||
| 11/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.92 | General |
| Category: Neurology | ||||||
| 11/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.82 | General |
| 11/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Neuromodulation | ||||||
| 11/01/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 674 | 1,053 | $367,557 | $101,473 |
| 2022 | 12 | 449 | 697 | $212,802 | $63,275 |
| 2021 | 12 | 557 | 1,073 | $274,020 | $85,478 |
| 2020 | 13 | 426 | 860 | $206,128 | $56,737 |
Total Patients
2,106
Total Services
3,683
Medicare Billing
$306,962
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 372 | $62,868 | $24,969 | 39.7% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 59 | 116 | $40,600 | $11,808 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $31,535 | $10,542 | 33.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 43 | 60 | $60,000 | $10,034 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 98 | $24,010 | $9,563 | 39.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 43 | 120 | $40,200 | $9,267 | 23.1% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 22 | 22 | $30,976 | $7,481 | 24.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 65 | 65 | $29,510 | $6,250 | 21.2% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 23 | 23 | $20,562 | $4,927 | 24.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 65 | 65 | $20,735 | $4,397 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $6,561 | $2,235 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 319 | $50,833 | $19,553 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $26,457 | $9,016 | 34.1% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 20 | 20 | $24,280 | $6,940 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 72 | $16,840 | $6,632 | 39.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 22 | 33 | $33,000 | $5,733 | 17.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 22 | 66 | $21,910 | $5,340 | 24.4% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2022 | 20 | 20 | $15,940 | $4,159 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $5,070 | $1,736 | 34.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 17 | 17 | $7,718 | $1,725 | 22.3% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 17 | 17 | $5,423 | $1,214 | 22.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 17 | 17 | $5,083 | $1,126 | 22.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 11 | 19 | $248.00 | $101.35 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 182 | 376 | $56,400 | $25,660 | 45.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 100 | 100 | $33,500 | $12,319 | 36.8% |
About Dr. Dong Wang, M.D
Dr. Dong Wang, M.D is a Neurology healthcare provider based in Duluth, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1497905913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dong Wang, M.D has received a total of $18,017 in payments from pharmaceutical and medical device companies, with $3,483 received in 2024. These payments were reported across 981 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($17,985).
As a Medicare-enrolled provider, Wang has provided services to 2,106 Medicare beneficiaries, totaling 3,683 services with total Medicare billing of $306,962. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Duluth, GA
- Active Since 09/20/2008
- Last Updated 01/15/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497905913
Products in Payments
- NURTEC ODT (Drug) $1,525
- Briviact (Drug) $1,349
- KESIMPTA (Drug) $1,074
- Aimovig (Biological) $931.35
- UBRELVY (Drug) $650.37
- EMGALITY (Drug) $579.67
- QULIPTA (Drug) $532.64
- Vimpat (Drug) $527.60
- AIMOVIG (Biological) $473.65
- APTIOM (Drug) $464.48
- Mavenclad (Drug) $456.04
- VYEPTI (Biological) $448.46
- RYTARY (Drug) $444.96
- INGREZZA (Drug) $325.58
- Fycompa (Drug) $292.68
- VALTOCO (Drug) $274.48
- NUPLAZID (Drug) $272.82
- AUSTEDO (Drug) $255.78
- COMIRNATY (Biological) $242.75
- Leqembi (Drug) $241.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Duluth
Gary Beaver, Do, DO
Neurology — Payments: $4,674
Neurology $4,674
Dr. Douglas Kaplan, Md, MD
Neurology — Payments: $3,284
Neurology $3,284
Shawnay Mazell, M.d, M.D
Neurology — Payments: $1,885
Neurology $1,885
Dr. Philip Kennedy, Md, MD
Neurology — Payments: $1,053
Neurology $1,053
Rebecca Meyerson
Neurology — Payments: $653.78
Neurology $653.78
Amber Erickson, Md, MD
Neurology — Payments: $247.79
Neurology $247.79